Chairpersons: Dr Maddalena LETTINO (ESC), Prof. Julia MASCHERBAUER (ESC), Dr Matias NORDABY (Boehringer-Ingelheim), Dr André ZIEGLER (Roche Diagnostics), Dr Isabelle RICHARD-LORDEREAU (Amgen), Industry chair of the CRT
12 May Replay - Session 1
12 May Replay - Session 2
13 May Replay - Session 1
13 May Replay - Session 2
Background and objectives of the meeting
The growing elderly population worldwide represents a major challenge for care-givers, healthcare providers and politicians.
Due to the life-long exposure to cardiovascular risk factors and the age-related comorbidities, cardiovascular diseases in elderly patients have a high prevalence and are frequently complicated, thus deserving a multifactorial approach.
Major problems to deal with are: paucity of scientific evidence from dedicated clinical trials, a narrow therapeutic window for most of the recommended therapies, frailty and cognitive deterioration, all affecting quality of care and outcome.
This meeting will appraise the burden of ageing in real life and the opportunity to revisit cardiovascular research, as well as pharmacological and interventional treatments in the elderly, with a final focus on quality of life and patient’s priorities.